Regulation of guanine nucleotide exchange factor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/122 (2006.01) A61K 31/404 (2006.01) A61K 31/4184 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/505 (2006.01) A61K 31/519 (2006.01) A61K 31/5377 (2006.01) A61P 25/00 (2006.01) A61P 25/16 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2533074

The invention relates generally to the methods of treating brain diseases and compounds for treating brain diseases, and more specifically relates to using compounds that are able to modulate guanine nucleotide exchange factors for proteins belonging to the Rap family of small GTPases to treat diseases of the brain, such as Alzheimer's and Schizophrenia.

L'invention concerne généralement des procédés de traitement de maladies cérébrales, des composés pour le traitement de maladies cérébrales, et plus spécifiquement l'utilisation de composés pour moduler les facteurs d'échange du nucléotide guanine pour les protéines appartenant à la famille Rap des petites GTPases, pour le traitement de maladies cérébrales, telles que la maladie d'Alzheimer et la schizophrénie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Regulation of guanine nucleotide exchange factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Regulation of guanine nucleotide exchange factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of guanine nucleotide exchange factor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1398075

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.